PDS Biotechnology Corporation · SWB:EU6

PDS Biotechnology Corporation financial statements

PDS Biotechnology Corporation's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000000000
Cost of revenue60.5K59.8K57.3K49.1K246.4K176.3K98.4K69.1K182.9K100.1K
Gross profit-60.5K-59.8K-57.3K-49.1K-246.4K-176.3K-98.4K-69.1K-183.0K-100.0K
Research and development19.0M22.6M27.8M29.4M11.3M7.92M6.10M830.7K34.3M24.8M
Selling, general and administrative12.5M13.5M15.0M12.2M10.2M6.79M11.0M14.3M17.7M14.7M
Operating income-31.5M-36.3M-43.0M-41.7M-21.4M-14.9M-21.0M-3.65M-52.0M-39.5M
Depreciation and amortization21.8K21.1K17.4K865.36K15.6K98.4K69.1K182.9K100.1K
EBITDA-31.5M-36.3M-43.0M-41.7M-21.4M-14.9M-20.9M-3.58M-51.8M-39.4M
Interest expense5.34M4.67M4.21M1.32M0033.6K3.60K2.18M1.20M
Income before tax-35.7M-38.5M-44.3M-42.1M-21.4M-14.8M-7.38M-3.84M-53.4M-40.7M
Income tax-1.17M-869.2K-1.41M-1.20M-4.52M0-381.5K0-2.59M-1.85M
Net income-34.5M-37.6M-42.9M-40.9M-16.9M-14.8M-7.00M-3.84M-50.9M-38.8M
Earnings per share, basic-0.74-1.03-1.39-1.43-0.66-0.89-1.441.15-1.65-1.34
Earnings per share, diluted-0.74-1.03-1.39-1.43-0.66-0.89-1.441.15

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents26.7M41.7M56.6M73.8M65.2M28.8M12.2M103.7K88.1M106.4M
Receivables3.90K13.5K
Current assets28.3M45.1M59.1M76.5M66.8M30.3M14.5M122.1K89.1M107.4M
Property, plant and equipment120.2K142.0K134.1K0865.44K21.1K29.5K3.42M3.42M
Total assets30.5M45.4M59.4M77.0M67.2M30.9M14.5M164.4K92.6M110.9M
Accounts payable3.57M1.68M6.98M1.22M1.31M1.42M1.20M1.31M4.37M3.47M
Current liabilities9.48M17.1M13.6M9.82M3.76M3.27M2.79M1.91M12.9M6.68M
Long-term debt11.7M9.20M19.5M23.0M30.0K17.4M15.0M
Total debt16.9M21.8M23.9M23.5M490.4K610.3K30.0K20.5M15.0M
Total liabilities21.2M26.4M33.3M33.0M3.99M3.76M2.79M2.23M30.2M21.6M
Shareholders' equity9.25M19.0M26.1M44.0M63.2M27.1M11.7M-2.07M-609.5K89.3M
Shares outstanding54.9M38.0M33.1M30.2M28.4M22.3M5.28M3.42M30.9M28.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-27.8M-35.0M-33.6M-25.7M-12.5M-13.1M-18.1M-1.57M-40.7M-32.2M
Capital spending0-29.0K0-4-4-5-10-188.7K-686.7K
Free cash flow-27.8M-35.1M-33.6M-25.7M-12.5M-13.1M-18.1M-1.57M-40.9M-32.9M
Cash from investing0-29.0K0029.4M0-188.7K-686.7K
Cash from financing12.8M20.2M16.4M34.3M48.9M29.8M750.0K1.50M22.6M9.08M
Dividends paid-271
Share buybacks-27129.8M750.0K721.2K17.6M315.0K
Change in cash-15.0M-14.9M-17.3M8.58M36.4M16.7M12.1M-53.4M-18.3M-23.8M